Search
Haemonetics Corp
HAEAdd to Watchlist
74.170USD
+1.440+1.98%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
3.37BMarket Cap
35.96P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Haemonetics Corp is 8.18, ranking 60 out of 203 in the Healthcare Equipment & Supplies industry. The average price target is 88.00, with a high of 108.00 and a low of 62.00.
Analyst Rating
Based on
11
analysts
Buy
Current Rating
87.778
Target Price
+20.69%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
117
Total
6
Median
9
Average
Company name
Ratings
Analysts
Haemonetics Corp
HAE
11
Medtronic PLC
MDT
33
Dexcom Inc
DXCM
32
Stryker Corp
SYK
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
30
1
2
3
...
24
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Haemonetics Corp's expected revenue for the next quarter?
Haemonetics Corp's expected revenue is 329.06M.
What is Haemonetics Corp's price target?
Analysts forecast that Haemonetics Corp's price target is USD 88.00, with the highest forecast at USD 108.00 and the lowest forecast at USD 62.00.
How have Haemonetics CorpHAE's recent earnings per share performed?
The market expectation was USD -0.44, while Haemonetics CorpHAE's earnings per share (EPS) for the previous quarter was USD 0.96. EPS for the next quarter is expected at USD 1.09.
What is the analyst rating for Haemonetics Corp?
Based on the ratings of Haemonetics Corp's stock from 11 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
